Cargando…
Validating intramyocardial bone marrow stem cell therapy in combination with coronary artery bypass grafting, the PERFECT Phase III randomized multicenter trial: study protocol for a randomized controlled trial
BACKGROUND: For the last decade continuous efforts have been made to translate regenerative cell therapy protocols in the cardiovascular field from ‘bench to bedside’. Successful clinical introduction, supporting safety, and feasibility of this new therapeutic approach, led to the initiation of the...
Autores principales: | Donndorf, Peter, Kaminski, Alexander, Tiedemann, Gudrun, Kundt, Guenther, Steinhoff, Gustav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419083/ https://www.ncbi.nlm.nih.gov/pubmed/22747980 http://dx.doi.org/10.1186/1745-6215-13-99 |
Ejemplares similares
-
Cardiac Function Improvement and Bone Marrow Response –: Outcome Analysis of the Randomized PERFECT Phase III Clinical Trial of Intramyocardial CD133(+) Application After Myocardial Infarction
por: Steinhoff, Gustav, et al.
Publicado: (2017) -
Stem cell registry programme for patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting: what benefits does it derive?
por: Nesteruk, Julia, et al.
Publicado: (2017) -
Angiogenic Potential of Bone Marrow Derived CD133(+) and CD271(+) Intramyocardial Stem Cell Trans- Plantation Post MI
por: Sasse, Sarah, et al.
Publicado: (2019) -
Safety of Simultaneous Coronary Artery Bypass Grafting and Carotid Endarterectomy Versus Isolated Coronary Artery Bypass Grafting: A Randomized Clinical Trial
por: Weimar, Christian, et al.
Publicado: (2017) -
Data on the fate of MACS® MicroBeads intramyocardially co-injected with stem cell products
por: Müller, Paula, et al.
Publicado: (2017)